Skip to main content
CVIR Endovascular

Table 3 Clinical outcomes of TAE without hysteroscopic resection

From: Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding

Expectant management group (n = 15)

Follow-up period [months; mean (range)]

3.4 (1–17)

Clinical success*

15 (100%)

Vascularity of retained placenta on TVUS or CE-CT [n (%)]

Few days after TAE

Marked reduction

8 (53%)

 Disappearance

7 (47%)

More than 1 month after TAE

 Disappearance

15 (100%)

Vaginal bleeding after TAE [n (%)]

 No bleeding

14 (93%)

 Minimal bleeding**

1 (7%)

  1. *Clinical success was defined as the absence of re-bleeding requiring additional treatment in the conservative treatment group
  2. ** Minimal bleeding spontaneously disappeared within 1 month
  3. TVUS transvaginal ultrasound, CE-CT contrast-enhanced CT, TAE transarterial embolization
Back to article page